Published in Exp Eye Res on January 04, 2005
TRPV1: contribution to retinal ganglion cell apoptosis and increased intracellular Ca2+ with exposure to hydrostatic pressure. Invest Ophthalmol Vis Sci (2008) 1.54
Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res (2010) 1.44
JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death. Neurobiol Dis (2012) 1.25
Pathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma. Exp Eye Res (2010) 1.13
Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models. Exp Eye Res (2009) 1.08
Phosphorylation-dependent interaction with 14-3-3 in the regulation of bad trafficking in retinal ganglion cells. Invest Ophthalmol Vis Sci (2008) 1.07
Network analysis of human glaucomatous optic nerve head astrocytes. BMC Med Genomics (2009) 1.03
Retinal cell responses to elevated intraocular pressure: a gene array comparison between the whole retina and retinal ganglion cell layer. Invest Ophthalmol Vis Sci (2010) 0.92
Lack of neuroprotection against experimental glaucoma in c-Jun N-terminal kinase 3 knockout mice. Exp Eye Res (2011) 0.90
Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma? Exp Eye Res (2009) 0.89
JUN regulates early transcriptional responses to axonal injury in retinal ganglion cells. Exp Eye Res (2013) 0.88
Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension. Mol Vis (2011) 0.85
Involvement of AP-1 and C/EBPβ in upregulation of endothelin B (ETB) receptor expression in a rodent model of glaucoma. PLoS One (2013) 0.82
Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure. Exp Eye Res (2015) 0.81
Endothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion Cells. Invest Ophthalmol Vis Sci (2015) 0.78
Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3. Invest Ophthalmol Vis Sci (2015) 0.77
Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons. Neuron (2017) 0.77
A Period of Controlled Elevation of IOP (CEI) Produces the Specific Gene Expression Responses and Focal Injury Pattern of Experimental Rat Glaucoma. Invest Ophthalmol Vis Sci (2016) 0.76
JUN is important for ocular hypertension-induced retinal ganglion cell degeneration. Cell Death Dis (2017) 0.76
Epigenetics and Signaling Pathways in Glaucoma. Biomed Res Int (2017) 0.75
Sirtuins Expression and Their Role in Retinal Diseases. Oxid Med Cell Longev (2017) 0.75
Discovery of novel inhibitors for the treatment of glaucoma. Expert Opin Drug Discov (2015) 0.75
Effect of ATF3-deletion on apoptosis of cultured retinal ganglion cells. Int J Ophthalmol (2017) 0.75
A feed-forward regulation of endothelin receptors by c-Jun in human non-pigmented ciliary epithelial cells and retinal ganglion cells. PLoS One (2017) 0.75
Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury. Mol Neurodegener (2017) 0.75
The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol (2002) 8.35
Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT. Ophthalmology (2007) 3.88
Choroidal thickness change after water drinking is greater in angle closure than in open angle eyes. Invest Ophthalmol Vis Sci (2012) 2.48
Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol (2005) 2.31
Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology (2008) 2.29
Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Invest Ophthalmol Vis Sci (2002) 2.24
Central corneal thickness and corneal hysteresis associated with glaucoma damage. Am J Ophthalmol (2006) 2.14
Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology (2008) 2.10
Development and validation of an improved neurological hemifield test to identify chiasmal and postchiasmal lesions by automated perimetry. Invest Ophthalmol Vis Sci (2014) 2.05
Risk factors and open-angle glaucoma: classification and application. J Glaucoma (2007) 1.99
The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest Ophthalmol Vis Sci (2002) 1.92
Biomechanics of the human posterior sclera: age- and glaucoma-related changes measured using inflation testing. Invest Ophthalmol Vis Sci (2012) 1.89
Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci (2007) 1.87
Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol (2006) 1.83
Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model. Invest Ophthalmol Vis Sci (2003) 1.83
Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci (2002) 1.82
Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci (2007) 1.74
Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology (2011) 1.74
Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology (2009) 1.74
Optic disc morphology in open-angle glaucoma compared with anterior ischemic optic neuropathies. Invest Ophthalmol Vis Sci (2009) 1.71
Adherence and persistence with glaucoma therapy. Surv Ophthalmol (2008) 1.57
Quantitative mapping of collagen fiber orientation in non-glaucoma and glaucoma posterior human sclerae. Invest Ophthalmol Vis Sci (2012) 1.56
Influence of corneal structure, corneal responsiveness, and other ocular parameters on tonometric measurement of intraocular pressure. J Glaucoma (2007) 1.52
Aqueous flow through the iris-lens channel: estimates of differential pressure between the anterior and posterior chambers. J Glaucoma (2004) 1.52
Outcomes and bleb-related complications of trabeculectomy. Ophthalmology (2012) 1.52
Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection. Exp Eye Res (2010) 1.51
Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest Ophthalmol Vis Sci (2008) 1.47
A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest Ophthalmol Vis Sci (2003) 1.46
Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology (2009) 1.46
The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci (2005) 1.40
Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death. Proc Natl Acad Sci U S A (2013) 1.36
Comparison of limbus-based and fornix-based trabeculectomy: success, bleb-related complications, and bleb morphology. Ophthalmology (2012) 1.36
Gene delivery to the eye using adeno-associated viral vectors. Methods (2002) 1.35
Scleral anisotropy and its effects on the mechanical response of the optic nerve head. Biomech Model Mechanobiol (2012) 1.32
Effect of CNTF on retinal ganglion cell survival in experimental glaucoma. Invest Ophthalmol Vis Sci (2008) 1.31
Glaucoma management among individuals enrolled in a single comprehensive insurance plan. Ophthalmology (2005) 1.26
Manometric calibration and comparison of TonoLab and TonoPen tonometers in rats with experimental glaucoma and in normal mice. J Glaucoma (2006) 1.25
Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss. Invest Ophthalmol Vis Sci (2011) 1.24
Clinician change detection viewing longitudinal stereophotographs compared to confocal scanning laser tomography in the LSU Experimental Glaucoma (LEG) Study. Ophthalmology (2002) 1.23
Intravitreal injections of neurotrophic factors secreting mesenchymal stem cells are neuroprotective in rat eyes following optic nerve transection. Invest Ophthalmol Vis Sci (2010) 1.18
Factors influencing career choices among graduating ophthalmology residents. Ophthalmology (2005) 1.17
Measurements of optic disk size with HRT II, Stratus OCT, and funduscopy are not interchangeable. Am J Ophthalmol (2006) 1.17
The effects of anesthesia, mouse strain and age on intraocular pressure and an improved murine model of experimental glaucoma. Exp Eye Res (2012) 1.17
In vivo time-lapse fluorescence imaging of individual retinal ganglion cells in mice. J Neurosci Methods (2007) 1.16
The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. Ophthalmology (2006) 1.16
Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia (2010) 1.14
Calibration of the TonoLab tonometer in mice with spontaneous or experimental glaucoma. Invest Ophthalmol Vis Sci (2011) 1.13
Evaluation of a combined index of optic nerve structure and function for glaucoma diagnosis. BMC Ophthalmol (2011) 1.12
The in vitro inflation response of mouse sclera. Exp Eye Res (2010) 1.11
Assessment of a race-specific normative HRT-III database to differentiate glaucomatous from normal eyes. J Glaucoma (2006) 1.09
Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma. Exp Eye Res (2006) 1.09
Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model. Mol Vis (2012) 1.09
Penetrating keratoplasty with pars plana glaucoma drainage devices. Cornea (2007) 1.08
Increased expression of iron-regulating genes in monkey and human glaucoma. Invest Ophthalmol Vis Sci (2004) 1.07
The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol (2006) 1.06
Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels. J Cell Physiol (2008) 1.06
Retinal ganglion cell morphology after optic nerve crush and experimental glaucoma. Invest Ophthalmol Vis Sci (2012) 1.06
Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest Ophthalmol Vis Sci (2002) 1.04
Studies of scleral biomechanical behavior related to susceptibility for retinal ganglion cell loss in experimental mouse glaucoma. Invest Ophthalmol Vis Sci (2013) 1.04
Donor scleral patch for treating hypotony due to leaking and/or overfiltering blebs. J Glaucoma (2005) 1.03
Scleral structural alterations associated with chronic experimental intraocular pressure elevation in mice. Mol Vis (2013) 1.03
Effect of patient-centered communication training on discussion and detection of nonadherence in glaucoma. Ophthalmology (2010) 1.03
Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection. Arch Ophthalmol (2006) 1.03
Inter-device variability of the Stratus optical coherence tomography. Am J Ophthalmol (2008) 1.01
Mechanism of retinal ganglion cells death in secondary degeneration of the optic nerve. Exp Eye Res (2009) 0.99
Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome. Ophthalmology (2007) 0.99
Outcomes of surgical bleb revision for complications of trabeculectomy. Ophthalmology (2009) 0.99
Gene expression profiling of purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci (2004) 0.99
Comparison of dynamic changes in anterior ocular structures examined with anterior segment optical coherence tomography in a cohort of various origins. Invest Ophthalmol Vis Sci (2014) 0.98
HRT III glaucoma probability score and Moorfields regression across the glaucoma spectrum. J Glaucoma (2009) 0.98
Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma. Br J Ophthalmol (2009) 0.97
Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy. J Biol Chem (2002) 0.96
A self-assessment instrument designed for measuring independent mobility in RP patients: generalizability to glaucoma patients. Invest Ophthalmol Vis Sci (2002) 0.95
Regulation of cell death and survival pathways in experimental glaucoma. Exp Eye Res (2007) 0.95
Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat. Invest Ophthalmol Vis Sci (2005) 0.95
Translating ocular biomechanics into clinical practice: current state and future prospects. Curr Eye Res (2014) 0.95
Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice. Ophthalmology (2009) 0.94
Variations in treatment among adult-onset open-angle glaucoma patients. Ophthalmology (2005) 0.94
Characteristics of progenitor cells derived from adult ciliary body in mouse, rat, and human eyes. Invest Ophthalmol Vis Sci (2007) 0.94
Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes. Invest Ophthalmol Vis Sci (2006) 0.92
Evaluation of an algorithm for detecting visual field defects due to chiasmal and postchiasmal lesions: the neurological hemifield test. Invest Ophthalmol Vis Sci (2011) 0.92
Comparison of optic nerve head topography and visual field in eyes with open-angle and angle-closure glaucoma. Ophthalmology (2008) 0.91
Intraocular injection of dibutyryl cyclic AMP promotes axon regeneration in rat optic nerve. Exp Neurol (2004) 0.91
The choroid is thicker in angle closure than in open angle and control eyes. Invest Ophthalmol Vis Sci (2012) 0.91
Long-term outcomes in fellow eyes after acute primary angle closure in the contralateral eye. Ophthalmology (2006) 0.91
Can diabetes be good for glaucoma? Why can't we believe our own eyes (or data)? Arch Ophthalmol (2009) 0.90
Increased choroidal thickness in patients with Sturge-Weber syndrome. JAMA Ophthalmol (2013) 0.90